Patent · US Active

[1,2,3]triazolo[4,5-D]pyrimidine derivatives

US9067943B2 · kind B2 · utility

5Cited by

3References

13Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Caterina Bissantz · Rixheim, FR
Uwe Grether · Weil am Rhein, DE
Atsushi Kimbara · Tokyo, JP
Matthias Nettekoven · Weil am Rhein, DE
Stephan Roever · Inzlingen, DE
Mark Rogers-Evans · Bottmingen, CH

Key dates

Filing date	Nov 19, 2012
Grant date	Jun 30, 2015
Priority date	—
Expiry date	Nov 19, 2032

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P29/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to a compound of formula (I)wherein A and R1 to R3 are defined as in the description and in the claims. The compound of formula (I) can be used as a medicament.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.